Vickram Tejwani, MD
Chronic Obstructive Pulmonary DiseaseAsthmaPulmonology
Highlights
Age Groups Seen
- Adult
Languages
- English
Gender
MaleAbout Vickram Tejwani
Biography
Dr. Vickram Tejwani is an Assistant Professor with dual appointments in the Departments of Pulmonary and Critical Care Medicine and Genomic Science and Systems Biology at the Cleveland Clinic Lerner College of Medicine. Dr. Tejwani has a clinical, educational, and research focus on airways disease (asthma, COPD, alpha-1 antitrypsin deficiency). He serves as a referral physician for complex asthma and COPD cases within Cleveland Clinic and provides disease specific education statewide and nationally. Dr. Tejwani is an active researcher whose work is funded by the NIH and national foundational grants. In addition to his clinical, educational, and research responsibilities, he holds leadership roles in the American Thoracic Society, European Respiratory Society and multicenter studies focused on airways diseases.
Dr. Tejwani completed his medical training at China Medical University followed by a year of research training at the Mayo Clinic. He then completed his internal medicine residency training at the Cleveland Clinic, where he was selected to be a Chief Resident. Following his residency he completed a clinical and research Pulmonary and Critical Care Fellowship at Johns Hopkins University, before returning to the Cleveland Clinic.
Locations
- A Building - Crile Building
- 2049 East 100th Street, Cleveland, OH 44106
- Get Directions
- Hillcrest Medical Building Atrium
- 6770 Mayfield Road, Suite 105, Mayfield Hts, OH 44124
- Get Directions
Education & Board Certifications
Education
- Fellowship: Johns Hopkins Hospital (Maryland), 2021
- Residency: Cleveland Clinic, 2016
- Medical Education: China Medical University, 2012
Board Certifications
- Pulmonary Disease: American Board of Internal Medicine, 2021
- Internal Medicine: American Board of Internal Medicine, 2016
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2025-11-27, Dr. Tejwani has reported the financial relationships with the companies listed below.
Consulting and/or Speaking. Dr. Tejwani receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:
- Regeneron Pharmaceuticals, Inc.
- Sanofi Genzyme
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.